Related Experiment Video
Updated: Mar 13, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Anti-allergic effects of His-Ala-Gln tripeptide in vitro and in vivo
Mamoru Tanaka1, Hiroyuki Watanabe1, Yoshinobu Yoshimoto2
1a Department of Nutrition , University of Kochi , Kochi , Japan.
Abstract:
We examined the inhibitory effects of HAQ (His-Ala-Gln) peptide on type-1 allergy in vitro and in vivo. HAQ peptide inhibited β-hexosaminidase release and intracellular Ca2+ levels of rat basophilic leukemia RBL-2H3 cells. Oral administration of a HAQ peptide-added diet (1 mg/mouse/administration) to C3H/HeJ mice for 14 days led to significant suppression of allergic symptoms, but did not reduce allergen-specific IgE or IgG1.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Drug Toxicity: Allergic Reactions
Allergic Drug Reactions

